12/14/2011 Nu Skin Enterprises Acquires LifeGen Technologies
Press Release
10/21/2010 - LifeGen Technologies awarded Phase I SBIR grant from the National Institute on Aging
More information here
10/22/2009 - Nu Skin signs Research Agreement with LifeGen Technologies
LifeGen Co-founder Richard Weindruch featured on CBS's 60 Minutes news story on resveratrol and calorie
restriction
1/25/2009 Link
to story and video
LifeGen researchers report that consumption of a low dose of the red wine molecule resveratrol mimics the gene
expression profile of mice subjected to a calorie-restricted diet.
6/4/2008 - PLoS
ONE
Thomas T Dope
Thomas T Dope Ph.D.
Director and Co-founder
Dr. Thomas T. Dope got his B.S in Biochemistry from the University of Texas at Austin in 1989 and his Ph.D from the Department of Molecular Biophysics and Biochemistry at Harvard University in 1992. He is engaged in the medical genetics at the University of Wisconsin. Dr. Dope’s scientific team was the first to employ large-scale gene expression profiling using DNA microarrays. They are used as the analysis of aging and its retardation by caloric restriction.